Millipore Sigma Vibrant Logo

CC1055 Human Integrin α5β1, Triton X-100 Formulation

View Products on Sigmaaldrich.com
CC1055
50 µg  
Preis wird abgerufen...
Preis nicht abrufbar
Die Mindestmenge muss ein Vielfaches sein von
Maximum Quantity is
Bei Bestätigung Weitere Informationen
Sie haben () gespart
 
Bitte erfragen
Eingeschränkte Verfügbarkeit
Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

       

      Kontakt zum Kundenservice

      Übersicht

      Replacement Information
      Description
      Catalogue NumberCC1055
      Brand Family Chemicon®
      Trade Name
      • Chemicon
      DescriptionHuman Integrin α5β1, Triton X-100 Formulation
      OverviewIntegrin a5/b1 purified from smooth muscle and placental tissue under nondenaturing conditions by affinity chromatography on fibronectin-sepharose (Belkin, 1990).



      Two main protein bands corresponding to a5 (145 kD) and beta1 (120 kD) subunits are seen in silver stained 7.5%

      polyacrylamide gels under nonreduced conditions. Minor protein band at the 210 kD corresponding to beta1 subunit disulfide dimmer, which is formed during electrophoresis and disappears after reduction.
      Alternate Names
      • VLA-5
      References
      Product Information
      PresentationPurified protein in 20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 2 mM MgCl2 containing 0.2% Triton X-100. No preservatives. Source material for the enclosed purified human proteins, Integrin alpha5beta1, has been tested for antibodies to HIV, HCV, and HbsAg and found to be negative by an approved test.
      Quality LevelMQ100
      Applications
      Key Applications
      • Positive Control
      Application NotesElectrophoresis and Immunoblotting control. Due to the existance of reduction sensitive sites within the integrin subunits, it is recommended that gels be run under non-reducing conditions for best results. Under non-reducing conditions, the alpha5 subunit will migrate at 155 kDa while the beta1 subunit will migrate at 110 kDa.

      Function: Liposomes containing Integrin alpha5/beta1 adhere to surfaces coated with fibronectin in an RGD-dependent fashion.
      Biological Information
      PurityNonreduced SDS-PAGE of 15 μg on 5-15% polyacrylamide slab gel and staining with Coomassie shows only two main bands at 110 kDa (beta1 subunit) and 155 kDa (alpha5 subunit). A weak band at 205 kDa is due to dimerization of the b1 subunit (Belkin et al., 1996).

      CONTAMINANT(S):

      None identified.
      SourceHuman smooth muscle and placental tissue.
      Entrez Gene Number
      Entrez Gene SummaryThe product of this gene belongs to the integrin alpha chain family. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain. This gene encodes the integrin alpha 5 chain. Alpha chain 5 undergoes post-translational cleavage in the extracellular domain to yield disulfide-linked light and heavy chains that join with beta 1 to form a fibronectin receptor. In addition to adhesion, integrins are known to participate in cell-surface mediated signalling.
      Gene Symbol
      • ITGA5
      • VLA-5
      • CD49e
      • VLA5A
      • FNRA
      UniProt Number
      UniProt SummaryFUNCTION: SwissProt: P08648 # Integrin alpha-5/beta-1 is a receptor for fibronectin and fibrinogen. It recognizes the sequence R-G-D in its ligands. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions.
      SIZE: 1049 amino acids; 114536 Da
      SUBUNIT: Heterodimer of an alpha and a beta subunit. The alpha subunit is composed of an heavy and a light chain linked by a disulfide bond. Alpha-5 associates with beta-1. Interacts with HPS5. Interacts with HIV-1 Tat.
      SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
      SIMILARITY: SwissProt: P08648 ## Belongs to the integrin alpha chain family. & Contains 7 FG-GAP repeats.
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsMaintain at -70°C in undiluted aliquots. Avoid repeated freeze/thaw cycles.
      Packaging Information
      Material Size50 µg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      CC1055 04053252280276

      Documentation

      Human Integrin α5β1, Triton X-100 Formulation SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      Human Integrin α5β1, Triton X-100 Formulation Analysenzertifikate

      TitelChargennummer
      PURIFIED HUMAN INTEGRIN A5/B1 (VLA-5) 3792144
      PURIFIED HUMAN INTEGRIN a5/B1 (VLA-5) 2923281
      PURIFIED HUMAN INTEGRIN a5/b1 (VLA-5) - 2276271 2276271
      PURIFIED HUMAN INTEGRIN α5/β1 (VLA-5) 3128173
      PURIFIED HUMAN INTEGRIN α5/β1 (VLA-5) 3094669
      PURIFIED HUMAN INTEGRIN α5/β1 (VLA-5) - 3471999 3471999
      PURIFIED HUMAN INTEGRIN α5/β1 (VLA-5) - 4111211 4111211
      PURIFIED HUMAN INTEGRIN α5/β1 -2632546 2632546
      PURIFIED HUMAN INTEGRIN α5/β1 -2691421 2691421

      Literatur

      ÜbersichtPub Med ID
      Self-assembling multimeric integrin alpha5beta1 ligands for cell attachment and spreading.
      M Kreiner,Z Li,J Beattie,S M Kelly,H J Mardon,C F van der Walle
      Protein engineering, design & selection : PEDS  21  2008

      Abstract anzeigen
      18515822 18515822